BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

839 related articles for article (PubMed ID: 27263465)

  • 1. The Dual Roles of NRF2 in Cancer.
    Menegon S; Columbano A; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
    Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
    Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer.
    Telkoparan-Akillilar P; Panieri E; Cevik D; Suzen S; Saso L
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33808001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer.
    Kang JS; Nam LB; Yoo OK; Keum YS
    Biochem Pharmacol; 2020 Jul; 177():114002. PubMed ID: 32360363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Nrf2 in tumor progression and its inhibitors in cancer therapy].
    Tian ZY; Yang Y
    Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):24-32. PubMed ID: 33645047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversy about pharmacological modulation of Nrf2 for cancer therapy.
    Milkovic L; Zarkovic N; Saso L
    Redox Biol; 2017 Aug; 12():727-732. PubMed ID: 28411557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1.
    Na HK; Surh YJ
    Free Radic Biol Med; 2014 Feb; 67():353-65. PubMed ID: 24200599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
    Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
    Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and role of nuclear factor-E2-related factor 2 (Nrf2) in multidrug resistance of hepatocellular carcinoma.
    Tian B; Lu ZN; Guo XL
    Chem Biol Interact; 2018 Jan; 280():70-76. PubMed ID: 29223570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
    Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs.
    Telkoparan-Akillilar P; Suzen S; Saso L
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis.
    Wasik U; Milkiewicz M; Kempinska-Podhorodecka A; Milkiewicz P
    Sci Rep; 2017 Mar; 7():44769. PubMed ID: 28333129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mazes of Nrf2 Regulation.
    Zenkov NK; Kozhin PM; Chechushkov AV; Martinovich GG; Kandalintseva NV; Menshchikova EB
    Biochemistry (Mosc); 2017 May; 82(5):556-564. PubMed ID: 28601065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells.
    Panieri E; Saso L
    Antioxid Redox Signal; 2021 Jun; 34(18):1428-1483. PubMed ID: 33403898
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary.
    Akino N; Wada-Hiraike O; Isono W; Terao H; Honjo H; Miyamoto Y; Tanikawa M; Sone K; Hirano M; Harada M; Hirata T; Hirota Y; Koga K; Oda K; Fujii T; Osuga Y
    Reprod Biol Endocrinol; 2019 Feb; 17(1):23. PubMed ID: 30760288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of the Nrf2 pathway: beyond the antioxidant response.
    Huang Y; Li W; Su ZY; Kong AN
    J Nutr Biochem; 2015 Dec; 26(12):1401-13. PubMed ID: 26419687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward clinical application of the Keap1-Nrf2 pathway.
    Suzuki T; Motohashi H; Yamamoto M
    Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.